About Du Page County Health Department
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Medications for pre-exposure to prophylaxis; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Local, county, or community government
License/Certification/Accreditation
State Substance use treatment agency; State mental health department; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Cash or self-payment
Payment Assistance Available
Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors)
Special Programs/Groups Offered
Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring
Transitional Services
Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Assistance with obtaining social services
Education and Counseling Services
HIV or AIDS education, counseling, or support; Substance use disorder education; Individual counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Medications for pre-exposure to prophylaxis; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Local, county, or community government
License/Certification/Accreditation
State Substance use treatment agency; State mental health department; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Cash or self-payment
Payment Assistance Available
Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors)
Special Programs/Groups Offered
Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring
Transitional Services
Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Assistance with obtaining social services
Education and Counseling Services
HIV or AIDS education, counseling, or support; Substance use disorder education; Individual counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Suicide prevention services
